Alterations in testosterone was reported in imatinib and dasatinib-treated patient with concomitant gynecomastia.167 Case reports showed that the development of painful gynecomastia with sunitinib therapy is due to its inhibition of the c-KIT/PDGFRA axis.216. The gene discussed is PDGFRA; the disease is Gynecomastia.